(3 minutes read)
· Johnson & Johnson (J&J) is planning to enter Ethiopia’s pharmaceutical sector
· Ambassador Hirut and the Embassy’s economic diplomacy section gave a detailed presentation to the company on the wide-ranging opportunities that existed in the pharmaceutical sector in Ethiopia
· They also briefed the company officials the government policies, , infrastructural, and market incentives, and other plus points of Ethiopia, while inviting the company to explore the market in Ethiopia
Johnson & Johnson (J&J) is planning to enter Ethiopia’s pharmaceutical sector. This was revealed by Mohsen Ramez, Managing Director of Pharmaceutical Companies of Johnson & Johnson, while talking to Hirtu Zemene, Ethiopia’s Ambassador to Belgium, Luxembourg, and EU institutions. Ramez said that J&J is already in the process of entering the Ethiopian market as it has begun the process of registering four of their medicinal products.
Ambassador Hirut and the Embassy’s economic diplomacy section gave a detailed presentation to the company on the wide-ranging opportunities that existed in the pharmaceutical sector in Ethiopia. They also briefed the company officials the government policies, infrastructural, and market incentives, and other plus points of Ethiopia, while inviting the company to explore the market in Ethiopia.
Herwig Janssen, the son of the founder and former president of the company was present during the discussions. He said that the company was interested in partnering with local pharmaceutical companies in Ethiopia for knowledge transfer and to bring about qualitative changes in pharmaceutical technology. Towards that, he agreed to exchange information and work together to further explore the business opportunities of the sub-sector in Ethiopia.
Janssen Pharmaceuticals is the pharmaceutical wing of Johnson & Johnson. It is regarded as one of the most innovative and inspiring pharmaceutical researchers of the 21st century.
